| BAS/BSCR24 Spironolactone reverses the adverse effects of aldosterone and hypoxia on adipose tissue. | |
| | |
MedLine Citation:
|
PMID: 20801815 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
We tested the hypothesis that aldosterone causes a loss of the normal anticontractile function of healthy fat via a hypoxia-related pathway, which can be rescued using spironolactone. Healthy rat mesenteric arteries ( approximately 250%muM diameter) and perivascular fat were investigated using wire myography and Perl's Prussian blue staining for activated macrophages. The effects of aldosterone%+/-spironolactone were assessed after incubation for 10 min and 3 h, and experimental hypoxia (95% N(2)/5% CO(2)) for 2.5 h. Contractile responses were calculated as a percentage of KCl contraction and expressed as mean+/-SEM. Macrophage activation was expressed semiquantitatively and expressed as macrophage abundance values (MAV). The anticontractile capacity of healthy fat was lost upon incubation with aldosterone (5 nM) (fat: 90+/-4% n=36, fat+10 min aldosterone: 165+/-5% n=25, fat+3 h aldosterone 172%+/-12% n=7) and was associated with an increase in activated macrophages (immediately fixed: 2.2+/-0.5% n=5 vs 10 min aldosterone: 3.8+/-0.4% n=5, p=NS; immediately fixed: 2.2+/-0.5% n=5 vs 3 h aldosterone: 4.7+/-0.3% n=5, p=0.0313). Spironolactone (10%muM) restored anticontractile activity after incubation for 3 h only (3 h:111+/-4% p<0.05, n=5) and caused a significant reduction in macrophage activation (3.0+/-1.0%, n=5). As for aldosterone, hypoxia caused an increase in contractility (149+/-17% n=15) and macrophage activation (5.5+/-0.5% n=5), which was reversed upon incubation with spironolactone (contractility: 120+/-12% n=5;MAV: 3.3+/-0.8%, n=3, p=0.500). Aldosterone ameliorates the anticontractile capacity of healthy fat by a common pathway to hypoxia, which correlates with an increase in the number of activated macrophages within adipose tissue. Spironolactone can restore the effect of hypoxia on contractility and macrophage activation in the absence of aldosterone. |
| | |
Authors:
|
S Withers; C Agabiti-Rosei; D M Livingstone; R Aslam; R A Malik; A M Heagerty |
Related Documents
:
|
467335 - Dexamethasone effect on the phospholipid content of isolated fat cell ghosts from adren... 16185675 - Effect of atorvastatin on sr-bi expression and hdl-induced cholesterol efflux in adipoc... 2801885 - Altered functional characteristics of rat macrophages during nephrosis. synergistic eff... 1909865 - Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion system. 14592845 - Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein a-i. 7322835 - Dietary obesity in adult and weanling rats following removal of interscapular brown adi... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Heart (British Cardiac Society) Volume: 96 ISSN: 1468-201X ISO Abbreviation: Heart Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9602087 Medline TA: Heart Country: England |
Other Details:
|
Languages: eng Pagination: e19 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: BAS/BSCR25 Importance of interaction between peroxisome proliferator-activated receptor-{alpha} and ...
Next Document: BAS/BSCR23 Apocynin treatment reduces high-fat diet-induced obesity and hypertension but has no sign...